12d
DPA International on MSNAnnual core operating profit increases for British pharma GSKAnnual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...
Hosted on MSN8d
Donna and Ex-Husband Ed Kelce Twin in '87' Jerseys to Support Son Travis — See Their 2025 Super Bowl Outfits!For the 2024 game, he went all out in Chiefs overalls, while Kylie opted for a Chiefs-red long-sleeve tee with the University ...
Harte Hanks Announces Leadership Transition to Accelerate Data-Driven Customer Experience Innovation
CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies connect ...
NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.
In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...
(Reuters) -Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times reported on Friday. Citadel has taken a short position worth 305 ...
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results